lorcaserin

Orexigen Calls Dr. Nissen
Forbes
Thu, 06/7/12 - 03:25 pm
Orexigen
obesity
Steve Nissen
Contrave
Vivus
Arena
lorcaserin
Cleveland Clinic
The Obesity Race: Update, Part 1
Seeking Alpha
Tue, 06/5/12 - 12:16 pm
Vivus
Qnexa
Arena Pharmaceuticals
lorcaserin
Orexigen
Contrave
Arena is Hands Down a Better Investment than Vivus
Motley Fool
Mon, 05/28/12 - 11:25 am
Arena Pharmaceuticals
Vivus
obesity
Qnexa
lorcaserin
Outlooks for Pfizer, Arena and Onyx Following Busy May
TheStreet.com
Mon, 05/21/12 - 12:28 pm
Pfizer
Arena Pharmaceuticals
Onyx
lorcaserin
JAK3 inhibitors
Merck
Carfilzomib
Mulling Arena Pharma's Future With Obesity Drug on Approval Path
TheStreet.com
Mon, 05/14/12 - 11:14 am
obesity
Arena Pharmaceuticals
FDA
lorcaserin
Arena Pharmaceuticals: FDA Approval Is Just The Beginning
Seeking Alpha
Sun, 05/13/12 - 01:34 pm
Arena Pharmaceuticals
lorcaserin
obesity
weight loss
Let the Obesity-Drug Wars Begin
Motley Fool
Sat, 05/12/12 - 11:24 am
Arena
Vivus
Orexigen
obesity
Contrave
Qnexa
lorcaserin
weight loss
Arena news boosts Orexigen, Vivus shares
Seeking Alpha
Sat, 05/12/12 - 11:16 am
Arena Pharmaceuticals
Orexigen
Vivus
lorcaserin
Contrave
Qnexa
obesity
weight loss
Arena Pharma: FDA Panel Live Blog
TheStreet.com
Thu, 05/10/12 - 11:13 am
FDA
Arena Pharmaceuticals
advisory panels
obesity
lorcaserin
Arena rallies ahead of FDA meeting
Marketwatch
Tue, 05/8/12 - 12:08 pm
Arena Pharmaceuticals
FDA
lorcaserin
Arena Pharma Poised to Rally on Positive FDA Panel Vote
Motley Fool
Mon, 05/7/12 - 11:26 am
Arena Pharmaceuticals
FDA
advisory panel
obesity
lorcaserin
Pfizer, Gilead Sciences, Arena Pharmaceuticals Face Big Dates in May
Minyanville
Mon, 04/30/12 - 10:12 pm
Pfizer
Arena Pharmaceuticals
Gilead Sciences
Vyndaqel
JNJ
Xarelto
ASCO
Talon Therapeutics
Marqibo
Quad
Truvada
lorcaserin
Protalix BioTherapeutics
Alexza
Adasuve
Arcalyst
Regeneron
Abbott Laboratories
Remicade
Don't Get Suckered In By Friday's Strong Rally In Arena Pharmaceuticals
Seeking Alpha
Mon, 04/30/12 - 10:18 am
Arena Pharmaceuticals
lorcaserin
Orexigen
Vivus
Arena Pharma's Data Points to Blockbuster Weight-Loss Drug Approval
Motley Fool
Fri, 04/27/12 - 11:30 am
Arena Pharmaceuticals
obesity
lorcaserin
3 Hot Biotech Stocks To Consider For New Obesity Drugs
Seeking Alpha
Sat, 04/21/12 - 11:46 am
Arena Pharmaceuticals
lorcaserin
Vivus
Qnexa
Orexigen
Contrave
Arena Pharma's Own Data Point to Weight-Loss Drug Rejection
TheStreet.com
Wed, 04/18/12 - 11:43 am
obesity
Arena
lorcaserin
6 Biotech Stocks With Huge Potential In May
Seeking Alpha
Wed, 04/11/12 - 10:56 am
taliglucerase alfa
Protalix BioTherapeutics
Alexza
Adasuve
Regeneron
Arcalyst
lorcaserin
Arena Pharmaceuticals
Quad
Truvada
Gilead
Talon Therapeutics
Marqibo
Arena: Which Way, Up Or Down?
Seeking Alpha
Thu, 04/5/12 - 08:41 am
Arena
obesity
lorcaserin
Focus On Upcoming FDA Drug Approval And Advisory Dates
Seeking Alpha
Wed, 04/4/12 - 11:18 am
FDA
XenoPort
Horizant
lorcaserin
Arena Pharmaceuticals
Qnexa
Vivus
Protalix BioTherapeutics
GSK
taliglucerase
3 Anti-Obesity Drug Companies Poised To Grow
Seeking Alpha
Tue, 04/3/12 - 08:59 am
obesity
Vivus
Orexigen
lorcaserin
Arena Pharmaceuticals
Contrave
Qnexa

Pages